Agonists and antagonists of p28 ebi3 and wsx/tccr for...

Details Agonists and antagonists of p28 ebi3 and wsx/tccr for... Agonists and antagonists of p28 ebi3 and wsx/tccr for...

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 38/17 (2006.01) A61K 38/20 (2006.01) A61K 39/395 (2006.01) A61P 9/10 (2006.01) A61P 11/06 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 29/00 (2006.01) A61P 37/02 (2006.01) A61P 37/08 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/566 (2006.01)

Patent

CA 2555421

Provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders. Also provided are methods of administering agonists or antagonists of IL-27 and IL-27 receptor.

L'invention concerne des procédés de modulation de l'activité de la cytokine, par exemple pour le traitement de troubles immunitaires et inflammatoires. L'invention concerne également des procédés d'administration d'agonistes et d'antagonistes vis-à-vis d'IL-27 et du récepteur d'IL-27.

Affiliated with

Also associated with

Rating

Agonists and antagonists of p28 ebi3 and wsx/tccr for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agonists and antagonists of p28 ebi3 and wsx/tccr for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonists and antagonists of p28 ebi3 and wsx/tccr for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1829866